BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34858325)

  • 1. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
    de Ruiter RD; Smilde BJ; Pals G; Bravenboer N; Knaus P; Schoenmaker T; Botman E; Sánchez-Duffhues G; Pacifici M; Pignolo RJ; Shore EM; van Egmond M; Van Oosterwyck H; Kaplan FS; Hsiao EC; Yu PB; Bocciardi R; De Cunto CL; Longo Ribeiro Delai P; de Vries TJ; Hilderbrandt S; Jaspers RT; Keen R; Koolwijk P; Morhart R; Netelenbos JC; Rustemeyer T; Scott C; Stockklausner C; Ten Dijke P; Triffit J; Ventura F; Ravazzolo R; Micha D; Eekhoff EMW
    Front Endocrinol (Lausanne); 2021; 12():732728. PubMed ID: 34858325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
    Chakkalakal SA; Shore EM
    Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1
    Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM
    J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.
    Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC
    Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations.
    Kresak JL; Walsh M; Tuzzolo A; Ordulu Z; Gregory J
    Neuropathology; 2023 Aug; 43(4):333-339. PubMed ID: 36642816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.
    Anwar S; Yokota T
    Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
    Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
    Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles.
    Eekhoff EMW; de Ruiter RD; Smilde BJ; Schoenmaker T; de Vries TJ; Netelenbos C; Hsiao EC; Scott C; Haga N; Grunwald Z; De Cunto CL; di Rocco M; Delai PLR; Diecidue RJ; Madhuri V; Cho TJ; Morhart R; Friedman CS; Zasloff M; Pals G; Shim JH; Gao G; Kaplan F; Pignolo RJ; Micha D
    Hum Gene Ther; 2022 Aug; 33(15-16):782-788. PubMed ID: 35502479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Identical Human Mutation in
    Casal ML; Engiles JB; Zakošek Pipan M; Berkowitz A; Porat-Mosenco Y; Mai W; Wurzburg K; Xu MQ; Allen R; ODonnell PA; Henthorn PS; Thompson K; Shore EM
    Vet Pathol; 2019 Jul; 56(4):614-618. PubMed ID: 31007133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.
    Towler OW; Shore EM; Kaplan FS
    Bone; 2020 Jan; 130():115116. PubMed ID: 31655222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva.
    Wentworth KL; Bigay K; Chan TV; Ho JP; Morales BM; Connor J; Brooks E; Shahriar Salamat M; Sanchez HC; Wool G; Pignolo RJ; Kaplan FS; Hsiao EC
    Bone; 2018 Apr; 109():104-110. PubMed ID: 29033382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.
    Kaplan FS; Zeitlin L; Dunn SP; Benor S; Hagin D; Al Mukaddam M; Pignolo RJ
    Bone; 2018 Apr; 109():281-284. PubMed ID: 29241828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations for the healthcare of patients with FOP].
    Seefried L; Banholzer D; Fischer R; Grafe I; Hüning I; Morhart R; Oheim R; Semler O; Siggelkow H; Stockklausner C; Hoyer-Kuhn H
    Orthopadie (Heidelb); 2023 Nov; 52(11):924-930. PubMed ID: 37603129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrodysplasia ossificans progressiva: clinical and genetic aspects.
    Pignolo RJ; Shore EM; Kaplan FS
    Orphanet J Rare Dis; 2011 Dec; 6():80. PubMed ID: 22133093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.
    Kaplan FS; Al Mukaddam M; Stanley A; Towler OW; Shore EM
    Bone; 2020 Nov; 140():115539. PubMed ID: 32730934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.
    Ratbi I; Bocciardi R; Regragui A; Ravazzolo R; Sefiani A
    Clin Rheumatol; 2010 Jan; 29(1):119-21. PubMed ID: 19795179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ACVR1
    Kaplan FS; Groppe JC; Xu M; Towler OW; Grunvald E; Kalunian K; Kallish S; Al Mukaddam M; Pignolo RJ; Shore EM
    Am J Med Genet A; 2022 Mar; 188(3):806-817. PubMed ID: 34854557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.
    Pignolo RJ; Bedford-Gay C; Cali A; Davis M; Delai PLR; Gonzales K; Hixson C; Kent A; Newport H; Robert M; Scott C; Kaplan FS
    Orphanet J Rare Dis; 2022 Apr; 17(1):168. PubMed ID: 35436894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP).
    Shore EM; Kaplan FS
    Bone; 2008 Sep; 43(3):427-33. PubMed ID: 18590993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.